DAXXIFY

View On IPO.GOV.AU

Registered: Registered/protected

Last updated on 11 Jan 2021

Owner Info

Revance Therapeutics, Inc. a Delaware Corporation

7555 Gateway Boulevard

Newark, CA, 94560 UNITED STATES OF AMERICA,

Serial Number

2123384 filed on 25 Sept 2020

Correspondent

Maxwells Patent & Trade Mark Attorneys Pty Ltd

PO Box R1466,

Royal Exchange,

SYDNEY, NSW, 1225 AUSTRALIA

DAXXIFY

Classification Information

2123384

25 Sept 2020

25 Sept 2030

WORD

30 Mar 2020

Status Date	Action Taken
11^th Jan 2021	IP Right Registered correspondence sent
11^th Jan 2021	IP Right Registration Published
11^th Jan 2021	Status change to Registered/Protected
28^th Oct 2020	Application Accepted correspondence sent
27^th Oct 2020	IP Right has been Examined
27^th Oct 2020	IP Right Acceptance Published
27^th Oct 2020	Status change to Accepted
30^th Sept 2020	Awaiting examination
30^th Sept 2020	Examination expedited
26^th Sept 2020	IP Right Filed correspondence sent